Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFIPEC: Intensified HIPEC and EPIC in Colorectal Cancer
NCT04861558Phase 3Recruiting
- Sponsor
- Uppsala University
- Start
- May 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of irinotecan, fluorouracil in colorectal cancer (CRC), peritoneal metastasis (PM), sponsored by Uppsala University. Started May 2021; status: recruiting.
02
Drugs
irinotecanfluorouracil
03
Conditions
colorectal cancer (CRC)peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT04861558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04861558.